Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Using index level provides a macro view of market direction, helping you balance stock-specific decisions with overall sentiment.
27,685 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
As investors chase rising income, DGRO has edged out VIG in recent returns. This report breaks down which fund compou...
TSMC delivers a record quarterly print as AI-driven demand powers growth. Margin expands and 2026 guidance rises, sig...
Bloom Energy surges in Q4 2025 on AI-driven data-center demand, delivering record revenue and EBITDA. Plug Power turn...
Apple reveals a staggering pay gap in its 2025 proxy, with CEO compensation at roughly $74 million vs. a median emplo...
The EUAD ETF has rebounded, prompting investors to focus on three defense stocks to watch as European budgets firm up...
A new push from across the political spectrum asks whether the public should share in AI profits. This article breaks...
Berkshire Hathaway's July 2026 moves reveal a rotating bet toward cash-generating, earnings-ready names. Delta Air Li...
Kontoor Brands posted Q4 2025 results with revenue above $1B and a solid earnings beat, driven by a key acquisition. ...
President Trump arrives in Beijing for high-stakes talks with Xi Jinping, pressing to open up China for American inve...
Three U.S. utility stocks are delivering reliable dividend income as rate-base growth supports earnings, offering a d...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...